indication

Delirium

Competitive landscape projected to DAR 0-100A’s launch window

as of 2026-07-01
Competitive set
1
1 approved · 0 pipeline

Projection timeline

actual past → guided future · protection walls overlaid
3 events
2018
2020
2022
2024
2026
2028
2030
today
DAR 0-100A launch window
guided / estimated ↑
actual ↓
focal / guidedapprovallabel expansiontrial readoutcongressnclustered events (click to expand)guided (dashed = directional)competitor patent cliff

Competitive set

resolved drugs with trials in this indication
drugWithdrawn
Ziprasidone
US-approved 2001 · Geodon
Phase 41 trial
OwnerPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Protection—

Market size

prevalence as a range, not a number